TEBENTAFUSP

tebentafusp 100 microgram/0.5 mL injection, 0.5 mL vial

TEBENTAFUSP (13831Y)

tebentafusp 100 microgram/0.5 mL injection, 0.5 mL vial
13831Y
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required (STREAMLINED)

Restriction  14825

Indication: Advanced (unresectable or metastatic) uveal melanoma
Treatment phase: Initial treatment - day 15
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 68 mcg # of repeats: 0 DPMA: $17,674.79 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Kimmtrak
(tebentafusp 100 microgram/0.5 mL injection, 0.5 mL vial)